News. Analysis. Insight.™ - 100 Years of Journalistic Excellence

Pfizer discovers, develops, produces and markets prescription medicines for humans and animals. Co. has two key segments: Pharmaceutical, which develops and produces products that treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye disease, endocrine disorders and allergies; and Animal Health, which discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Co. also operates several other businesses, including the manufacture of empty soft-gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals.

Industry	Health
Sector	Pharmaceuticals
# of Employees	98,000
Shares Outstanding	8.1B
Market Cap	149.2B
Enterprise Value	261.9B

52-Week High	$18.99
52-Week Low	$11.68
P/E Ratio	15.41
EPS	$1.20/shr
Dividend	$0.64/shr
Yield	3.46%

Ms. Magaret M. Foran

Associate General Counsel; Secretary; Senior Vice President

Ms. Sally Susman

Chief Communications Officer; Senior Vice President

Mr. Jeffrey B. Kindler

Chief Executive Officer; Chairman

Mr. Frank A. D'Amelio

Chief Financial Officer; Senior Vice President

Ms. Loretta V. Cangialosi

Controller; Vice President

Mr. Richard H. Bagger

Senior Vice President

Dr. Joseph M. Feczko M.D.

Senior Vice President; Chief Medical Officer

Mr. Ian C. Read

Senior Vice President; Division Officer

Mr. Allen P. Waxman

Senior Vice President; General Counsel

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs